Showing results (151-160 of 196) with videos related to

Sort By:
Pageof 20
Transplantation|November 19, 2016
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo OsseoMichele Malagola, Valeria Cancelli, Cristina Skert, et al.
Transplantation and Cellular Therapy|November 6, 2024
Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic TransplantationChiara Nozzoli, Martina Pucillo, Luisa Giaccone, et al.
Current Research in Translational Medicine|October 26, 2024
Evaluation and management of hepatic dysfunction, portal hypertension and portal/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMTGiorgia Battipaglia, Nicola Polverelli, Joe Tuffnell, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 2, 2026
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMTJan Styczynski, Gloria Tridello, Nina Knelange, et al.
Bone Marrow Transplantation|January 22, 2024
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMaría Queralt Salas, Diderik-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation|February 2, 2021
Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMTGiorgia Battipaglia, Katya Mauff, Lotus Wendel, et al.
Transplantation and Cellular Therapy|April 6, 2024
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction SyndromeMirko Farina, Maria Chiara Scaini, Antonella Facchinetti, et al.
Blood Advances|August 20, 2020
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-CyJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
American Journal of Hematology|April 2, 2020
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long-term follow up of a phase III studyFrédéric Baron, Fabio Efficace, Laura Cannella, et al.
Bone Marrow Transplantation|September 7, 2023
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMTJuan Carlos Hernández-Boluda, Diderik-Jan Eikema, Linda Koster, et al.
Pageof 20